Free Trial

Colgate-Palmolive (NYSE:CL) Shares Sold by Schroder Investment Management Group

Colgate-Palmolive logo with Consumer Staples background

Schroder Investment Management Group lessened its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 2.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,275,084 shares of the company's stock after selling 59,798 shares during the period. Schroder Investment Management Group owned approximately 0.28% of Colgate-Palmolive worth $206,828,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Allianz SE purchased a new position in Colgate-Palmolive during the fourth quarter worth about $8,645,000. Transamerica Financial Advisors Inc. boosted its position in shares of Colgate-Palmolive by 30.1% during the 4th quarter. Transamerica Financial Advisors Inc. now owns 8,240 shares of the company's stock worth $750,000 after purchasing an additional 1,905 shares during the period. OneAscent Wealth Management LLC increased its holdings in Colgate-Palmolive by 4.2% in the 4th quarter. OneAscent Wealth Management LLC now owns 3,725 shares of the company's stock valued at $339,000 after purchasing an additional 149 shares during the last quarter. Allstate Corp purchased a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $2,087,000. Finally, denkapparat Operations GmbH acquired a new position in Colgate-Palmolive during the fourth quarter worth $334,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CL. Stifel Nicolaus decreased their target price on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a research note on Monday, February 3rd. Royal Bank of Canada reiterated a "sector perform" rating and set a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research note on Monday. JPMorgan Chase & Co. increased their price objective on Colgate-Palmolive from $97.00 to $99.00 and gave the company an "overweight" rating in a research note on Friday, March 14th. Finally, Wells Fargo & Company boosted their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $102.06.

View Our Latest Stock Analysis on CL

Colgate-Palmolive Stock Performance

Shares of NYSE CL traded up $2.80 during mid-day trading on Thursday, hitting $96.35. 2,197,507 shares of the company were exchanged, compared to its average volume of 4,499,147. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The firm has a market cap of $78.15 billion, a price-to-earnings ratio of 27.37, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The stock has a 50 day simple moving average of $90.03 and a 200-day simple moving average of $93.36. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the business earned $0.87 EPS. On average, sell-side analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be issued a $0.52 dividend. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a dividend yield of 2.16%. The ex-dividend date is Thursday, April 17th. Colgate-Palmolive's dividend payout ratio (DPR) is currently 59.09%.

Colgate-Palmolive declared that its Board of Directors has authorized a share buyback program on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to buy up to 6.8% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's board of directors believes its stock is undervalued.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines